Podcast: Will A ‘Netflix’ Model Solve Antibiotic Reimbursement Challenges And Spur R&D?

 
• By Lucie Ellis-Taitt

Infex CEO Peter Jackson discusses the state of antimicrobial resistance in the UK, and globally. He highlights the potential of a new “Netflix” style subscription model for antibiotic reimbursement, as well as future challenges for biotechs in the anti-infectives space. 

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,

More from C-Suite Speaks

More from Leadership